ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001334.1|Cladoniamide_1 # 1 # 894 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.766	BGC0001334.1|Cladoniamide_1 	1	894	+	Loose	700	25.409	mef(D)	31.43	3005089	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCTGTGGCTCGGCCCGCCGGGCCTGGCCGGTACGGCGCCGCTGCCCGCGCTGCTGGTGATGCTGCCCGTGGCGATGAGCGTGACGGCGGTGCCCGTCCTCGCCTGTGTCATCGACGAACGCGGGCCCGGGCTCGGCCGGGCCGCGCCGCTCGCCCTGATGTCCGCGATCCTGCTGGACACCGTGGCGTGGCTGCTGCTGGCCGTCGCGCTGGGGCTGGCCGCCGGGGGACTGTGGGGGGTGGCCGGGGCGTTCGCCGCGCTCGCCGTCGGGCTGCTGCTGGCGCACGGAGGCCGCCGCGCACTCGCCCGCCCCCGGATCACGGCGGCCGCCGCCCGCCGCCCCACGGCCGCCGCCGTGCTGCTCGGCGGGCTCGCGCTGCTGGCGGCGACCGGGGCCCACGGCGCGGGACTCACCGCCGTCCTCGGCGCGTTCCTCGCGGGCGTCATGGTCCCCCATGACCCCGACGGCCCCTGGACCCGGGCGGTCGCCGTCGTCGCCCGGGTCGGCCGGGTGCTGCTCCCGGTGTTCTTCGTCGGCACCGGGATCACCCTGTTCACCGAATCGGCGGGCTCGCTGCCCTGGTCCGCGACCCTGCTGTGCACCGCGCTGGCGATCGTCGGCAAGGTCGGCGGCGGATACCTCGGCGCGCTGTGGGCGGGGGAGGACCGCCGGACCGCGCTGCGGGTCGGCGTCCTGGTCAACACCCGCGGACTCACCGAGATCGTGGTCCTCCAGGTGGGCTGGGCGGCGGGCATCCTCACCCCGGGACTGTTCCTCGCGATGCTGGTCATGGCGCTCGTCACCACCGTCCTGACCGGACCGCTGCTCTCCCTCATCGACCACCACGCGGCCTCCCGGGAGCCGCTCGTGCGAACAGGCGGTGTTCCGTGA	VLWLGPPGLAGTAPLPALLVMLPVAMSVTAVPVLACVIDERGPGLGRAAPLALMSAILLDTVAWLLLAVALGLAAGGLWGVAGAFAALAVGLLLAHGGRRALARPRITAAAARRPTAAAVLLGGLALLAATGAHGAGLTAVLGAFLAGVMVPHDPDGPWTRAVAVVARVGRVLLPVFFVGTGITLFTESAGSLPWSATLLCTALAIVGKVGGGYLGALWAGEDRRTALRVGVLVNTRGLTEIVVLQVGWAAGILTPGLFLAMLVMALVTTVLTGPLLSLIDHHAASREPLVRTGGVP	MKNNKWKKKFIAIYIGQFFSLLSSAAVQFSIIWWLTDKTGGSPLVLTLAGLAGFLPQALAGPFAGTITDRYSRKLMMILADMTVALGSLILFISLYFYEINISFVILILAIRSLATAFHMPALQASIPLLVPEDDLTKAAGWGQTVSSISNITGPAVGMSILAASSIEWVLLLDVLGAVIASGILLFIYIPKIQNQNQQSIDSKGFFIEMKDGYNALVNHPILLKLTFVMTSVAVLYIPLGTYFPLITRNHFNKGVVEAGIVEIIFAVGLIIGGSFLGILGDKFNKINTMTTGILLMGIALFLTGILSPSLFYFFVVLAGLVGFSGPLFSAPFYALIQSEIEPHLLGRVFSFVTSISLLATPLGYVIAGLLIEITNVSTLFSIIGVLIIFNGIIINRLK	74.44	gnl|BL_ORD_ID|2806|hsp_num:0	3823			813	990	
BGC0001334.1|Cladoniamide_2 # 891 # 1424 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.743	BGC0001334.1|Cladoniamide_2 	891	1424	+	Loose	700	25.409	norA	29.41	3000391	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAAACTGTCCCCAGAGATCACCCCGACCCGGTTCCGCGCCCTGATGGCCGGGTTCCCCAGCGGTGTCGCCGTCCTCACGGCCACGGACCCCGACGGCGGGCGCCCGTGGGGCATGACGTGCTCCTCCGTGTGCGCGGTGTCGCTCGCCCCGCCCACCCTGCTGGTCTGTGTGCGCACCGGCAGCCCCACCCTGGACGCGATGCTCCGCCGGAGCGCCTTCGCGGTGAACCTGCTCCACGACGGGGCCCGCGCCACCGCCGAACTGTTCGCGTCCGGGGCGCCCCACCGGTTCGACCAGGTCCGCTGGGAGTACCCGGTGACGGGCGGCGGACCGCATCTGGTCGAGGACGCGCACACCGTCGCGGACTGCGAGGTCAGCGGGCACCAGGTGGTCGGCAGCCACGCCGTGGTGTTCGGGGAGGTGACCGCGGTCCACCACAGGAGCCCGCCGCGACCCCTGCTGTACGGGCTGCGCCGGTACGCCGCGTGGCCCCTGCCCGACGTGGACACCGTCTCGTGGGTGGCCCCCTGA	MKLSPEITPTRFRALMAGFPSGVAVLTATDPDGGRPWGMTCSSVCAVSLAPPTLLVCVRTGSPTLDAMLRRSAFAVNLLHDGARATAELFASGAPHRFDQVRWEYPVTGGGPHLVEDAHTVADCEVSGHQVVGSHAVVFGEVTAVHHRSPPRPLLYGLRRYAAWPLPDVDTVSWVAP	MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPQKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN	45.74	gnl|BL_ORD_ID|1427|hsp_num:0	1554			516	618	ciprofloxacin; acriflavine; norfloxacin
BGC0001334.1|Cladoniamide_3 # 1598 # 2434 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.767	BGC0001334.1|Cladoniamide_3 	1598	2434	-	Loose	200	25.7942	vanH gene in vanF cluster	34.92	3002945	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGTCCGATGCGACCCTGCCGGCGAACCCGCCGGACACCGGCGCGGAGGTCCTCGTCCGCACCCATGACGGACTGCGGCTCGCGGGCACGCTCCTGGTACCGCCGGGGCATCACGACGGCTCCCGGGACGCGGCGCTGTTCCTGCACGGGTCGGGTGCCGACCGGGAGCAGGGCGGGCTTTTCACCCGGGTCGCCCGGGGTCTGGCGGACGGCGGGGTGGCCACACTCCGCTTCGATCTGCCGGGCCATGGGCACAGCGAGGGGCGGCAGGCGGAGCTGAGCCTGTCCGGGCTGCTCAATCTGATCGGCTCCGGGCTGCGGGAGCTGCGGGAGCGGACCGGTGCCGCCCGGATCGCCGTACTGGCGGCGGGACTCACGGGCGGGGTGGCCGCGGGGTACGCGGCGCGGCGCGGCGACGAGATCGGCCGGCTGGTGCTGTTCGATCCGCTGATCGACTACCAGGAGCACTTCACGGCGGATTCGCCGCGGTGGCGCGGCGGCCGGCTGACCGAGCCCGCGGGCCGGACGCTGCTGGCAGACGGCGCGCTCGCGTCTGCCTGCGGACTGGCGGCGGGCCGGGCGATGCTCAACGAGGTCTTCTGGCTCCAGCCGCGCGGGGTGCTCGGCGCGGTGACCGCGCCCACCCTGATCGTGCACGGTACGGGCGCGGCACGGGTCCCCGTGGCGTCGTCACGGTCGGCGGCCGGGGCGCTCACCGCCGAGCACCGTCTCGTGGAGCTCCCGCCCGGCGGGGACGCGCTCGCGGGGGCGGTGTCGGCGGCCCTCGCCTGGCTGCTGCCCGCGGCCACCGACGCGGGCGACGACGCCCCTGGGTGA	MSDATLPANPPDTGAEVLVRTHDGLRLAGTLLVPPGHHDGSRDAALFLHGSGADREQGGLFTRVARGLADGGVATLRFDLPGHGHSEGRQAELSLSGLLNLIGSGLRELRERTGAARIAVLAAGLTGGVAAGYAARRGDEIGRLVLFDPLIDYQEHFTADSPRWRGGRLTEPAGRTLLADGALASACGLAAGRAMLNEVFWLQPRGVLGAVTAPTLIVHGTGAARVPVASSRSAAGALTAEHRLVELPPGGDALAGAVSAALAWLLPAATDAGDDAPG	MKNIGITIYGCERDEAEVFNELSPRFGVIPAITSSAVSETNAMLAPGNQCISVGHKSEISESILLALKESGVKYISTRSIGCNHIDVKAAESMGIAVGNVAYSPDSVADYTLMLMLMAIRNAKSIVSRAEKYDFRLDTVPGKELREMTVGVLGTGQIGKAVIERLRGFGCHVLAYGHSKEAAANYVSLNELLQKSDILTIHVPLGTDTYHMIGHEQIEAVKQGAFLINTARGGLVDTGALIKALENGRLGGAALDVLEGEEGLFYFDCTQKPIDNQLLLKLHKMPNVIITPHTAYYTGRALYDTVEKTILNCLEFERRETLE	86.34	gnl|BL_ORD_ID|1652|hsp_num:0	1790			153	339	vancomycin
BGC0001334.1|Cladoniamide_4 # 2776 # 4335 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=3-4bp;gc_cont=0.735	BGC0001334.1|Cladoniamide_4 	2776	4335	+	Loose	600	29.261	Streptomyces venezuelae rox	35.94	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGCGCAGGAACGGCTCGGCGGCCACGGGCGTCACCCGCCCGTACCCGCCCCTCTCGACCATCCCCCGCCCGCCCGCGTCCGCCGGGCATCCGCCACCGGGGCCCAAACGGATCACCGTCGTCGGCGCCGGTATCGCCGGGCTGATAGCCGCCCATGAACTGGAACGCCTGGGCCATCGCGTCCAGGTGCTGGAGGCGGGACTCGCCCCCGGCGGCCGGGTCCGCACCCACGGGTTCAGCGGACGCGCCCACGGACCGCTCGTGGAACTGGGCGCCATGCGCATCCCCGCCTCGCACCACCTCACCATGCAGTGGATCGACCGGCTGCGGCTGAGCGACCGCGTACGGCAGTTCCGCACCCTCTTCTCCGACGACGCCAGTTATCTGGCGACCCCGGCCGGACACGTCCGGGTCCGGGACGCCTCACCGGTCCTCGTCGAGGAGTTCCGCCGGAGCCTGCCGCCGGGCCCGGACCACCGGCCCGAGACCCTGCTGTGCGCGGCCTGGCTCGCGGCGAGCGTCCACGCGGTCGCCCCCGGCACCTTCGGACGCGGACTGCACACCGATCTGCCCGTCGAACTCCTCGGCCTGCTCGCCGGCATCGACGTCCGGCCCTACCTCGTCGGCGGCGCCGCGACCCGGATCGACCTCAACCGGTTCTTCGCCCACCACCAGGGGTTCGCCGCGCACGGCCGGTTCCGCTACTTCTTCGACGACGTCGTCACCGAGACGTCCTCGGCGCTGTTCCGGCTGGACGGCGGGATGGACCAGATACCCAGACGGCTCGTCGCCCAGCTGCGCGGACCCGTCCGCTGGGGCCGCCGGGTGGTCGGGCTGCACGCACGGCCCGACGGGGTCACGGTCGACACCCGGCACGGACTGTCCACGGAACGGTTCGACTGCCCGTACGTCCTGTGCACCCTGCCGTTCTCCGTACTGCGCCGGATGCCGCTGACCGGGGTCGGCGACGACAAGACCGCGGTGGTCAACGACATGCAGTACTGGCCCGCCACCAAGATCGCCCTGCACTGCCGGGAGGCGTTCTGGGAGAACGACGGGATCAGCGGCGGCGGCTCCTTCACCGGGGGACTCACCCGCCAGACCTACTACCCGCCGGTGGAGAGCGACCCCCGGCTGGGCGCCGCGCTGCTCGCCAGCTACACCATCGGCCCCGACGCGGAGGCGCTCAGCGAGGTGCCGAAGGACAAGCGCGTCGCCACCGTCCTCGGTGAACTCAAGCCGATGCACCCCGAACTGGCCTCCCCGGGCATGCTCCTCGACGCCCGGAGCCAGGTGTGGGGCGAGGACCCGCTGAGCATGGGCGCCGCCTCCGTGCGGTGGAGCAAGGACCCGGACACCGCCGAGGAGGAACGACGGCTCGCCGCCGCGCCGCAGGGCGCCCTGTTCTTCGCCGGCGAGCACTGCTCCTCGACCCCCGCGTGGATCGAGGGCGCGATCGAGTCGGGGCTGACCGCGGCCCGGGAGATCCACGGCCATGTCCCGCTGAACCGCGGGGTGACGGCGCCGGGACACCGGGTGGGCGCGGGCGGCGCGCGATGA	MRRNGSAATGVTRPYPPLSTIPRPPASAGHPPPGPKRITVVGAGIAGLIAAHELERLGHRVQVLEAGLAPGGRVRTHGFSGRAHGPLVELGAMRIPASHHLTMQWIDRLRLSDRVRQFRTLFSDDASYLATPAGHVRVRDASPVLVEEFRRSLPPGPDHRPETLLCAAWLAASVHAVAPGTFGRGLHTDLPVELLGLLAGIDVRPYLVGGAATRIDLNRFFAHHQGFAAHGRFRYFFDDVVTETSSALFRLDGGMDQIPRRLVAQLRGPVRWGRRVVGLHARPDGVTVDTRHGLSTERFDCPYVLCTLPFSVLRRMPLTGVGDDKTAVVNDMQYWPATKIALHCREAFWENDGISGGGSFTGGLTRQTYYPPVESDPRLGAALLASYTIGPDAEALSEVPKDKRVATVLGELKPMHPELASPGMLLDARSQVWGEDPLSMGAASVRWSKDPDTAEEERRLAAAPQGALFFAGEHCSSTPAWIEGAIESGLTAAREIHGHVPLNRGVTAPGHRVGAGGAR	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	109.03	gnl|BL_ORD_ID|4833|hsp_num:0	5820			297	480	rifampin; rifaximin; rifapentine
BGC0001334.1|Cladoniamide_5 # 4377 # 6062 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.735	BGC0001334.1|Cladoniamide_5 	4377	6062	+	Loose	600	133.265	Streptomyces venezuelae rox	30.38	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAACCCCTCGCACGACACCGGCGTACTGATCGTCGGCGGTGGCCCCACCGGTATGGCCACAGGTCTGGAACTGCGGTCCCGCGGCGTCGACTTCACCCTCGTCGAAGCGGGTGACGGCAGCGTCACCCACCCCAAGGTCAGCGCGATCGGTCCGCGTTCCATGGAGTTCTTCCGCCGCTGGGGCATGGCCGACCGGGTCCGCGGCGCGGGCTGGCCCGGGGACCACACCCTGGACTGCGTCTGGGTCACCCGGGTCGGCGGCCATGAGCTGTACCGGCTGCCGCGCCGCACCATGGACACCCGCGCCCCGTTCCGGCACACCCCCGAACCCGACGCCATCTGCCCCCAGCACTGGCTCGGCCCCCTGCTCCGCGAGGAACTGGGCGTGCACCCCGGCGGCCCGGTCCGGATGCGGACCCGGATGACGGGCTTCACCCAGGACGCGGACGGCGTCACCGCACGGCTCACCGACGAGGCCACGGGCCGGACCACCACCCTGCGGGCCCGCTATCTGATCGCCTGCGACGGCACCTCCTCGCAGGTCCGCAAGGACGCCGGTATCGAGGCCCCCGCCCGCCACCGCACCCGGGTCTGCCGCAACATCCTCTTCCGGGCGCCACGGCTGCGCGAGGAACTGGGCGAACGCAACGCCAACTTCTTCTATCTGCTGATGTCCTCCGCCCTGCGCTTCCCGCTGCGCGCCCTCGACGGCAAGGACCTGTACCGGCTCACCGTCGGCCTGCTGGGCCACCCGGACTCGCTGGTCGACGCGGAGACCCTGGTCCGCCGGGCCATCGCCCATGACACCCCCGTCGAGGTGCTGTCCGACAACCAGTGGCATCTGGTGCACCGGGTCGCGGAGAACTTCCGCGCGGACCGGGTGTTCCTCGTCGGGGACGCCGCCCACACCCTGTCGCCCTCCGGCGGCTTCGGGATGAACACCGGGATCTGCGGCGCCGCCGACCTGGGCTGGAAGCTCGCTGCCGCGTTCGACGGCTGGGCGGGCCCCGGACTCCTCGACAGCTACACCACCGAGCGGCGGCCCGTGGCGCTGGAAGGCTTGGAGGAGGCCAACCGGCATCTCGTCCGGGCCTGGGCGCGGGAGATCCCCGGGGAACTCAACGACGACACCCCCGAGGGCGAACGGCACCGCCGCTCCCTGGGCGCGGACCTCGCCGCCGGGCCGGTCGCCAAGGAGTTCGACGCCCCGGAGATCCATCTCGGCTTCAGCTACGCCGACTCCCCCCTGGTCGTCCCCGATCCGACCGTCCCCGCCGACGCGCACGACGACCGGCGGCCCAACTCCCGGCCCGGCTCCCGCGCCCCGCACGCCTGGGTGAAGCCCGGGACGTCGACCCTGGACCTGTTCGGCGACGGGTTCGTGCTGATGTCCAGCACCCGCTCGGCCCGCACCGACGGCTTCACCCGCGCCTTCGCCGACCGGCGCGTCCCGCTGACCGTCGTCCACTGCGAGGTCCCCGAGGTCGTCGAGAGCCTGGAGCGGCCCTTCGTCCTCGTCCGCCCCGACGGACATGTGGCGTGGCGCGGCCATGAACTGCCCGACGACCCCGCCGCCGTCGCCGCCCGGGTCACCGGCGCGGGTACGGGGACCGGTACGGGTACCCGCGCAGGTACCGGCACGGACTCCGGTACGGGCGCCAGCGGCACCGGGGGAGCGCCATGA	MNPSHDTGVLIVGGGPTGMATGLELRSRGVDFTLVEAGDGSVTHPKVSAIGPRSMEFFRRWGMADRVRGAGWPGDHTLDCVWVTRVGGHELYRLPRRTMDTRAPFRHTPEPDAICPQHWLGPLLREELGVHPGGPVRMRTRMTGFTQDADGVTARLTDEATGRTTTLRARYLIACDGTSSQVRKDAGIEAPARHRTRVCRNILFRAPRLREELGERNANFFYLLMSSALRFPLRALDGKDLYRLTVGLLGHPDSLVDAETLVRRAIAHDTPVEVLSDNQWHLVHRVAENFRADRVFLVGDAAHTLSPSGGFGMNTGICGAADLGWKLAAAFDGWAGPGLLDSYTTERRPVALEGLEEANRHLVRAWAREIPGELNDDTPEGERHRRSLGADLAAGPVAKEFDAPEIHLGFSYADSPLVVPDPTVPADAHDDRRPNSRPGSRAPHAWVKPGTSTLDLFGDGFVLMSSTRSARTDGFTRAFADRRVPLTVVHCEVPEVVESLERPFVLVRPDGHVAWRGHELPDDPAAVAARVTGAGTGTGTGTRAGTGTDSGTGASGTGGAP	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	117.86	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	1374	rifampin; rifaximin; rifapentine
BGC0001334.1|Cladoniamide_6 # 6059 # 7321 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.743	BGC0001334.1|Cladoniamide_6 	6059	7321	+	Loose	1500	28.8758	rphA	31.25	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGACCCCCGCCACGGCCCCCGCCGCCCTGCCCCCGTTCGGCCTCACCGGCTGGCCCGCCGAACGCCTCGCCGACCCCTACCCGGTCTACCGCCGCTACCGCGCCGCCGCCCGCGTCCACCGGGCCGAACCGGACGGTACGGCACCGACGTTCTACGTACTCGGCCACGACGAGGTCGCCAAGGTCCTCAGCGCCCCCGTCTACGGCCGCAGCCCCCGCCGCGCCACCGGCGGCGCCCCACCCGCGACGGTCCCGAACGGCCACTCCGCGCTGCGGAGCATGGTCGAGAACTGGCTGGTCTTCCTCGACCCGCCCCGCCACACCGAACTGCGGTCCCTGCTGAACCGGGAGTTCACCCCCGGTGTCGTCACCGATCTGCGCGGCCGGATCCAGGACATCGCCGTCGGCCTCCTCGCCGAACTCACCGCCGAGGCCGCCCGCACCGGGACCGTGGACCTCGTCGAACGGTTCAGCGCGCCCTTCCCGATCCTGGTGATCTCCGAACTGCTCGGGGTGGACCGGACCGACTGGGCCTGGCTGCGCGAACAAGCCGTCGGGGTGCAGCAGGCGAGCAGCAGCCGCGCCGCGCTGCGCCCCGACGCGCACCACGTCGCCGAGACCGCCGCCCGCGAACTCACCTCTTACTTCCTGGAACTGGCCGCCCGGCGCCGCGCCGAACCCGCCGCCGACCTGGTGTCGCTGCTCGTGTCGGCGCAGACCCGGGGCGAACCGCTGACCGACGCGGAGATCGTCGCGACCTGCGTGCATCTGATGACGGCGGGCCACGAGACCACCACCAACGTCCTCAGCAAGTCCGTCCTCACCCTCACCGCGCGGCCCGCGCAGCTCGCCCGGCTGCGGGCGGCGCCGCTCGTCCCGGCGCCCGCGGTGGAGGAACTCGTCCGCTTCGACCCGCCGGTGCAGGCCGTGACCCGCTGGGCCTACCGCGATGTGGTGCTCGGCGGGCACCACGTACCCCGCGGCAGCAAGCTCTTCGCCGTGCTCGGGGCCGCCAACCGCGACCCGGCGCGCTTCCCCGACCCGGACACCCTCGACCTGGACCGCGGCGGACGCAACCTCGCCTTCGGGCTCGGCGTCCACTACTGCCTCGGCGCCGGCCTCGCCCGCACCGAGATCGAGATCGGACTGGGACTGCTGCTGCGCGCCCTGGCCGCCCTCGGCGACAGTGAGGTCGACGAGGTCCACTACCCGTACGACCTCGTGTTCCACGGGCCCGAGCGGCTCACCCTGCGGCTGCGCTGA	MTPATAPAALPPFGLTGWPAERLADPYPVYRRYRAAARVHRAEPDGTAPTFYVLGHDEVAKVLSAPVYGRSPRRATGGAPPATVPNGHSALRSMVENWLVFLDPPRHTELRSLLNREFTPGVVTDLRGRIQDIAVGLLAELTAEAARTGTVDLVERFSAPFPILVISELLGVDRTDWAWLREQAVGVQQASSSRAALRPDAHHVAETAARELTSYFLELAARRRAEPAADLVSLLVSAQTRGEPLTDAEIVATCVHLMTAGHETTTNVLSKSVLTLTARPAQLARLRAAPLVPAPAVEELVRFDPPVQAVTRWAYRDVVLGGHHVPRGSKLFAVLGAANRDPARFPDPDTLDLDRGGRNLAFGLGVHYCLGAGLARTEIEIGLGLLLRALAALGDSEVDEVHYPYDLVFHGPERLTLRLR	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	48.55	gnl|BL_ORD_ID|890|hsp_num:0	910			1023	1263	rifampin; rifaximin; rifabutin; rifapentine
BGC0001334.1|Cladoniamide_7 # 7302 # 8963 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.745	BGC0001334.1|Cladoniamide_7 	7302	8963	-	Loose	550	165.236	Nocardia farcinica rox	35.79	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCGTGACGCACACGATTGTGACGTCCTCGTCGTCGGGGCGGGTCCGAGCGGACTGACCGCCGCGCTGGCGCTGGCGCAGCAAGGGGTCCGGGTCAGGGTCGTGGACCGCGCCGCGGGGCCCGTGGAGGAGGCGCGGGCGGCGATCGTGCACGCCCGCACGCTGGAGCTGCTGGACCGGCTCGGGGTCGCGGCGCAGGCGGTGGCGCGGGGGCTGCCGATCACCCAGGTGGCCATCCATGAGCGGGGCCGGCACGCGGGGCGGATGCCGCTCGCGGGCGCGGGCACCGCGGCCTGGACCCGGTTCCCGTACGCGCTGGCGCTGGAGCAGTTCGAGACCCAGCGGTTGCTGGTGGAGGCGCTGGCCGAGCACGCGGTGGACGTCGAGTGGGACAGCGCGCTCGACTCGCTGGCCGACACCGGTGAGGGGGTACGTGTCACGGTGCGGCGCACGGACGGCGAGGAGACGGTGACGGCGCGCTGGCTGATCGGCGCGGACGGCGCGAGCAGCACCGTCCGGCAGTCGCTGGGGCTGGAGTTCGGGGGGCGGACGTATCCGCAGAGCGGGATGCTCGCGGATGTCGTGCTGGACGCCGATCTCGGGGTGCGGGGGATGCGGCTGAACCTGACCCGGGGCGGTTTCGTCGGCATCCTGCCGCTGGCGAGCGGGCGTTGCCGGCTGTTCGGGGTGGTGCCGCCGTCGGTGCACAAGGCCCAGGAGCCCGTCGAGACCTCCCACGAGGCGTACGCGGCGCTGGAACCGGAGGTGCTGCACCGCTGGTTCGCCGACTACTTCCGGGTGGACGCGCGGCTCCAGGAGATCGTGTGGGCGTCGATGTTCCGTTTCCACAGCCGGATCGCGCCGCGGTTCCGGGTGGGCTCCTGCTTCCTGATCGGGGACGCCGCCCATATCCACAACCCGGCGGGCGGGCAGGGGCTGAACCTGGGGGTGGGCGACGCGGTCAATCTGGCGTGGAAGCTGGCGCAGGTGGTGCACGGCCAGGCGCCGCCGTGGTTGCTGGACACCTACGAGTCGGAGCGGCGGCCCATCGCGCGGACCGTCCTCAAGCGCACCGATCTGGGGTTCCGCGCGGAGACCGGCGACGGGGCGGTCGCGGTGTGGATGCGGACCCAGGTGGCGGCCCGGGTGGTCGGCGTGGTCAGCCGTCTCGCGCCGGTGCGGCGGATGTTCTTCCATATGTTCTCGCAGCTGTGGATCGGCTACCGGGGTTCACGCGCGGTCGCCGCCGCCCGGCCGGTGACGGGCGGGCTGCGGCCCGGCGACCGGGCCCCGTACGCGCTGCTGGCGCGGGCCGGTGACGGGACGGGCAGTGTGCTGGACCTGACCCATGGCAGCGGCTATCACGTCCTGGGGTTCGCGGCGGACCCCGGCGCGGCGGGGCTGGACGTCCAGGAGCTCGCGGAGCTGCTGGACGACCGCTACCCGGGGATGGTGACGGTCCACGCGGTGCCGCCGCAGGAGACGGCGGCGTACCGCGCGTACCAGGTGAAGGGGGCGCGGCTGGTGGTGGTCCGGCCGGACGGGCATCTCGGGGCCGTGGTGGACCTCCCGGCCCCGGACGCCGTCGGCGCGCTGGTCGCCTTCCTCGACCGGGTGCTGCTGCGGGCGACCTCGCCGGAGGTCAGCGCAGCCGCAGGGTGA	MRDAHDCDVLVVGAGPSGLTAALALAQQGVRVRVVDRAAGPVEEARAAIVHARTLELLDRLGVAAQAVARGLPITQVAIHERGRHAGRMPLAGAGTAAWTRFPYALALEQFETQRLLVEALAEHAVDVEWDSALDSLADTGEGVRVTVRRTDGEETVTARWLIGADGASSTVRQSLGLEFGGRTYPQSGMLADVVLDADLGVRGMRLNLTRGGFVGILPLASGRCRLFGVVPPSVHKAQEPVETSHEAYAALEPEVLHRWFADYFRVDARLQEIVWASMFRFHSRIAPRFRVGSCFLIGDAAHIHNPAGGQGLNLGVGDAVNLAWKLAQVVHGQAPPWLLDTYESERRPIARTVLKRTDLGFRAETGDGAVAVWMRTQVAARVVGVVSRLAPVRRMFFHMFSQLWIGYRGSRAVAAARPVTGGLRPGDRAPYALLARAGDGTGSVLDLTHGSGYHVLGFAADPGAAGLDVQELAELLDDRYPGMVTVHAVPPQETAAYRAYQVKGARLVVVRPDGHLGAVVDLPAPDAVGALVAFLDRVLLRATSPEVSAAAG	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	116.91	gnl|BL_ORD_ID|4834|hsp_num:0	5821			3	1002	rifampin
BGC0001334.1|Cladoniamide_8 # 9273 # 10004 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.725	BGC0001334.1|Cladoniamide_8 	9273	10004	+	Loose	550	31.9574	RlmA(II)	29.76	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGACCGACCAGGCCCCCGTCCCGCCCCCACCACAGCCGTACTTCGACGACCTCGCGGACCTGTACGAGCGGTTCACCAGCATCCGGGACGGCGCCACCAGCCCGGTCCGCTCCTGGCTCGTCGGCCAGCTGCCCAAGGGGCAACGGGCCCTCGACATAGGCTGCGGCGGCGGCAACAACTGCGTGATGCTCGCGGAACGCTACGACGAGGTGGTCGGCGTCGACATCTCCCGCCGGATGCTCGACATCGCCGCCGCCAAACCGGCCCGGGTCCCGGTGCGTTACCAGCACCGCAGCGCGCTGGACCTCACCCCCGCCGCCGACGGCACCTTCGACCTGGTGATGTCCGTCAACGCCGTCTTCCATCTGGGCCCCGCCCCCCGGGTGCTGCCCCGGCTGCGCGACCTCGTCGCCCCGGGCGGCCGGCTCGTCGTCATCGACGTCACCCGGCCCGACGCGACCGGCACGGACACCGACGCCGCGCCGCCCGCCGAACGCGACACGTACGCCTTCGACACCGCGCGCACCATCTACGAGGTCTCCGGCGACGCGGACGCCGCCGCCGACTCGCTGCGGATGATGCTCCACCCGCGCTGGCTGGAGATGAGCGCCGCCCATATGCCGCTCACCTACGGCGAGTTCGTCCGCGCCTACCGCGAACAGCTGCCCGGAGTGCGAATCACCCGCGACCTCATCCCCACCATGAGCGCCGCCGTCTGGGACGCCCCGTGA	MTDQAPVPPPPQPYFDDLADLYERFTSIRDGATSPVRSWLVGQLPKGQRALDIGCGGGNNCVMLAERYDEVVGVDISRRMLDIAAAKPARVPVRYQHRSALDLTPAADGTFDLVMSVNAVFHLGPAPRVLPRLRDLVAPGGRLVVIDVTRPDATGTDTDAAPPAERDTYAFDTARTIYEVSGDADAAADSLRMMLHPRWLEMSAAHMPLTYGEFVRAYREQLPGVRITRDLIPTMSAAVWDAP	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	86.17	gnl|BL_ORD_ID|2052|hsp_num:0	2274			297	546	tylosin; mycinamicin
BGC0001334.1|Cladoniamide_9 # 10001 # 13273 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.730	BGC0001334.1|Cladoniamide_9 	10001	13273	+	Loose	700	26.9498	ADC-127	23.75	3006302	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	GTGAGCGTGCTCGACGTGCCCCGGGTGCACTTCGCCGGGGCCGCCGTCACCCGGCTGCCCACCGGCCCCCGCTCCGGACTGTACGACCTCGCCACCGGGCGGGCCCTCACCGACGACGGCCCTTTCCCGCTGGAACGCCCCGCCCGCGAGTACCACGACCTGCTGCGCGCCCGCGGCGAGCGCTACGAACCCGACGGCACCCTCACCCCCGACGGCCGCTTCTCCACCACCACCGGCTGGAACTTCGGCGGCAACGGCCACTTCTGGATCGACGCCCGGGTCACCGGCTGCGAACACACCCCCGGCCGCGCCGCGACCGACGACCCGCTGGTGGGCCGCGCCGTCGACCTGTGGGGCCACTTCTGCGACTACACCGCGGGCACCGTCAACCGCTGCCGTGTCCTCGATGTCGACCCCGCGTCCCCGTGGACCACCACCGTCATGATCGGCCAGCTCGCCCTCGGCCGCCTCGGCCGCTCCCACGACGTGGGCTATCTGCTCACCGGCGACGTCACCGGTATGAGCCCGCCGCGCTGGCCCAACGCCCGCTACATCGACGACGTCGGCCCGCACCCCCTCGCCGACCGGTTCCGCCGCTCCGTCGTCCACCAGTTCGCCGTCGAACGCGGCACCGGACTGCACTGGCTGGACGGCTCCGCCGACTCACCGGCCCTCACCGCGCTGCGGGACCTCCTGGACTCCGGCGCCGCCGACGGACTCGTCGTCCAGCTCGCCCTGTCCAACATGTCCACCCCCACCGACAACGACCAGCCCGACTTCTGGGACCTGCGCGGTGTCCTCGCCCCCTGGCACGCCCACGAACTGCGCACCTACCCCGCCGGACGGCTCCTCACCGGCCGCCGCGTACGGGCCGCCGGTCACCACGCACCCCTGCACAACCTCACCGTCCGCGTGGACGACGAGCACGTCACCGCGAACCTCGTCACCGCGCTGCCCGTCACCGGCCGCGCCCCGCTGCGCGGCCCCGGCCCCACCCACCGCACCGGACCCCTCGCCGACCTCGGCGACCTCCAGCTGCGCGCCGCCGACGGCACCCTCGTCGCCGTCGTCCGCGGCGCCGACTACCTCGGCGCCGGCTACCGGCGCACCGGCGGACTGCTCACCCTCGACCGGATCGACGGCCGCACCGGCGAACCCGCCGGCCCGCTGCGGATCACCTCGCCGGACGGCACCGTACTGGCCGACGAGGAGGAGACCGTCGTCCAGTCCGACGAGGCGGCGCTGTTCCTCGAACACCCCAACCCCCGCACCGGCGAAGACTTCGCGGTCCAGGTGCCCGTCCGCTCCTACGTCCGGGGCCGCCCCGCACGGGCCACGGGCATCCGGGTCCAGCAGTACCCCAACCCCCGCGCGCTGCCCCTCGACCCGGCCGCGCAGTCGCCCGACGCCCGCCCCGCGGACATCCCCGTCACCGCGTTCCTGGCCCCCGGCCGCGCCGACTACACCGCCGACAGCCTGCTGTCCACCGACGAACACGGCCACGGCACCCTCACCCTGCGGGGCGCCGCGGCGGGCGCCGCCCTGGTCCTGCTGCTCCCCGCCGGTGAACAGCCCCCCGCCGACCCCGCCGAGCCGGGCTCAGCCGCCCGCGGCTACGACCACGACGACGACCTCGGCTACTGGCCCGCCGCCGGCAGCATCGCCGTCCGGGTGCTGCCCGACCACTGGCACCTCGACGACCTGCCCGACAGCGCCATCACCTTCCCGCTGGTCTACCGCCAGGCCCTCGCCCCCTACGAACTCCTCTACTCCTTCATGAGCGACGAGGTGCTCAGCCTCGCCGACGAGTTCAAGGTCGAGACATACGCCCGGCTGATCTGGCACGTCAGCGCCCCCGAACACCGGGACCGGACGTTCTACATGCCCTCCACCCGCGATCTGAGCGCCCCTCAGATCCGGCTGCTGCTGCGGTACATGCTCGCCGACGAGGCGAAACGGCAGACCCCGCCCGTCCTCGTCCCCCCGCACCGGACCCCCGGCACGATCACCACCCGCGACGCCCTGCTGCGGGCCCTGCGCCAGGCCGCGGCCATCGAACTCGCCACCATGATCCAGTACCTGTACGCGGCGTACTCGGTCCCCACCCACGGCGCCGCCCGCCACTACGTCGAGCGCGGCGAATGGACCCCCGCCCAGCTTCTCCTCGCCTGCGGCGAAGGCCCGCAGACCCTCAGCAACGGCATCCGCGGCAGCCTCACCAACGTCGCCCGCGAGGAGATGATGCACTTCCTCGCCATCAACAACATCCTCATGGCCATGGGCGCCCCCTTCCAGGTGCCCGACATCGACTTCGGGACGTTCAACCACCGCATCGACGTCCCCCTGGAGTTCTCCCTCGAACCCCTCGGCCTCGGCAGCGTCCAGCGGTTCATCGCCCTCGAACAGCCCCACACCCTCACCCAGGAGATCGCGGGCAACGACTCCACGGCCGACGGCGGGACCGCCTACCGCTACGGATCGCTCAGCGAGCTGTACGCCGCGATCCGCGACGGCATCCAGCGCGTCCCCGGCGCGTTCCTCGTCCGCAAGGGCCGCGGCGGCGGGGAACACCATCTGTTCATGCGGGAGTCCGTCAACGCCGTGCACCCCGACTACCAGCTCGAAGTGGACGACGTCACCAGCGCCGTCTTCGCCATCGACTTCGTCACCGAACACGGCGAAGGCGGCTCCATCCCCTCCGTCCTGCCCGACGAGGACTCCCACTTCGACACCTTCCTGCGGATCTCCGACGCCCTCGTCCACGAACGCGCGCAGGGACCGAACGGCCGCGCCGTGCCCTGGAACCCCGCCTACCCCGTGCTCCGCAACCCCACCCTGGACCTGCGGAGCACCGCCAAGGACCCCGTCACCCACGAACCCGCGCGCCGCGCCATGACCGTCTTCAACCGCTCCTACGCCCTGGCCATGCACCTGATGGTCCAGCACTTCGGCCACAGCCCCGACAAGAGCCTGCGCCGCTCCCGGCTCATGAACTGGGCACTGGACATCATGACCGGCGTACTGCGCCCGGTCGCCGAACTCGTCGTCACCCTGCCCTCCGGACGCCCCGGCCGCACCGCCGGACCCTCCTTCGAACTCGGCACCGTCCCCCAGTACATCGCCCGGCCCGATGTGGCCGCCGCCTGGCTGGCCCGCGAGTTCGACGAGACCGCCTCCCTCGCCCGGGGCTGCCCCGCACTCACCCCCGCCGTGGCCGACCTCCTCGCCTTCATCGGCGACCGGCTGCGCACCATGGACCCCCGGGAGATGTGA	MSVLDVPRVHFAGAAVTRLPTGPRSGLYDLATGRALTDDGPFPLERPAREYHDLLRARGERYEPDGTLTPDGRFSTTTGWNFGGNGHFWIDARVTGCEHTPGRAATDDPLVGRAVDLWGHFCDYTAGTVNRCRVLDVDPASPWTTTVMIGQLALGRLGRSHDVGYLLTGDVTGMSPPRWPNARYIDDVGPHPLADRFRRSVVHQFAVERGTGLHWLDGSADSPALTALRDLLDSGAADGLVVQLALSNMSTPTDNDQPDFWDLRGVLAPWHAHELRTYPAGRLLTGRRVRAAGHHAPLHNLTVRVDDEHVTANLVTALPVTGRAPLRGPGPTHRTGPLADLGDLQLRAADGTLVAVVRGADYLGAGYRRTGGLLTLDRIDGRTGEPAGPLRITSPDGTVLADEEETVVQSDEAALFLEHPNPRTGEDFAVQVPVRSYVRGRPARATGIRVQQYPNPRALPLDPAAQSPDARPADIPVTAFLAPGRADYTADSLLSTDEHGHGTLTLRGAAAGAALVLLLPAGEQPPADPAEPGSAARGYDHDDDLGYWPAAGSIAVRVLPDHWHLDDLPDSAITFPLVYRQALAPYELLYSFMSDEVLSLADEFKVETYARLIWHVSAPEHRDRTFYMPSTRDLSAPQIRLLLRYMLADEAKRQTPPVLVPPHRTPGTITTRDALLRALRQAAAIELATMIQYLYAAYSVPTHGAARHYVERGEWTPAQLLLACGEGPQTLSNGIRGSLTNVAREEMMHFLAINNILMAMGAPFQVPDIDFGTFNHRIDVPLEFSLEPLGLGSVQRFIALEQPHTLTQEIAGNDSTADGGTAYRYGSLSELYAAIRDGIQRVPGAFLVRKGRGGGEHHLFMRESVNAVHPDYQLEVDDVTSAVFAIDFVTEHGEGGSIPSVLPDEDSHFDTFLRISDALVHERAQGPNGRAVPWNPAYPVLRNPTLDLRSTAKDPVTHEPARRAMTVFNRSYALAMHLMVQHFGHSPDKSLRRSRLMNWALDIMTGVLRPVAELVVTLPSGRPGRTAGPSFELGTVPQYIARPDVAAAWLAREFDETASLARGCPALTPAVADLLAFIGDRLRTMDPREM	MRFKKISYLILPSLFIFNTSIYAGNTSKEQDIKKVVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKSVNGNTIFELGSVSKLFTATAGGYAKTKGKISFNDTPGKYWKELKNTPIDRVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNQIGEYRQYSNPSIGLFGKVVGLSMNQPFSQVLENTIFPSLHLKHSYVNVPKTQMQNYAFGYNQENQPIRVTPGPLDAPAYGVKSTLPDMLSFIDANLNPQKYPADIRRAIDETHKGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	284.60	gnl|BL_ORD_ID|3160|hsp_num:0	4198			99	315	
BGC0001334.1|Cladoniamide_10 # 13273 # 14538 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.732	BGC0001334.1|Cladoniamide_10 	13273	14538	+	Loose	600	71.2478	Streptomyces venezuelae rox	28.4	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAGCGGCCCGGCTCCCACCCGCACCACCGTCTGCGTGGTCGGCGGCGGCCCCGCGGGCGCGATGCTCGGCCTGCTGCTGGCCCGCTCCGGCGTGGACGTCGTCGTCCTGGAGAAGCACCACGACTTCCACCGCGACTTCCGCGGCGACACCGTCCACCCCGCCACCCTGCGCGTTCTCGACCAGCTCGGCCTCATCGACCGCTTCCACGCGCTCCCGCACCAGAAGGTCACCACCATCGGGGTGATCCAGGACGGCCACCGCATCGACATCGCGGACTTCAGCCGGCTACGGGTCCCCTACCCCTACATGGCCTTCGTCCCCCAATGGGACTTCCTCGACCTGATCACCGCCGAGAGCGCCCGCCACCCCGCGTACCGGCTGCTGATGGGCACCGCGGCCACCGGGGTGCTGCGCGACACCGACGGCCGCGTCAGCGGCGTACGGACCCGGGGCCCCGACGGCGCCGCCGACCTCCGCTGCGCCCTGGTGGTCGCCGCCGACGGCCGCCACTCGGCGCTGCGGGCCGCGGTGGGCGCCCGGCCGAAACTCATCGGCTCCTCCCTCGACGTGGGCTTCTTCCGGATCTCCCGCCGGCCGACCGACCCCGACGAGGGCATCTGCGTCCGGGTCGGCAACGGCAAGATCTTCGGCGCGACCGACCGCGGCACCTACTGGCAGATGTCCTACGAGACCACCCGCGGCGGCTTCGACCGGGTCAGGCACGCGGGACTCGACGCGTTCCGCGCCGACCTCGCCGCACTGGTGCCCTTCCTCGCCGACCGGGTCCACGAACTGCGCTCCCTGGACGACATCAGCCTGCTGGAGGCCCGGATCGACCGGCTCGCCCGCTGGCACCGGCCCGGACTGCTGTTCATCGGGGACGCCGCACACGCCATGTCCCCCGTCGCCGGGTTCGGCGTCAACCTCGCCGTCCAGGACGCCGTCGCCACCGCCAACGCCCTCTGCGCGCCCCTGCTGCGCGCCCAGCGCACCGGCGCCGCCTTCGACGACAGCCTCCTCACCAAGGTCCGCCGGCGCAGACTGGTCGCCACCGCCCTCTCCCAGGGACTGCAACGCGCCACCCAGCGCTTCGGCATCGACACCACCCTCAACGGCTCAGGACAGCCGCCCGCGCCCCGGCTGTTCGAACGATTCCGGCCCGCACAGCTCCTGATGAGCAGGGTCATCGGGGTCGGCTTCCGCCCCGAACACATCCGCACACCCCCGGCCCGCCCCGCCGACCACGAGAAGGACCCGACATGA	MSGPAPTRTTVCVVGGGPAGAMLGLLLARSGVDVVVLEKHHDFHRDFRGDTVHPATLRVLDQLGLIDRFHALPHQKVTTIGVIQDGHRIDIADFSRLRVPYPYMAFVPQWDFLDLITAESARHPAYRLLMGTAATGVLRDTDGRVSGVRTRGPDGAADLRCALVVAADGRHSALRAAVGARPKLIGSSLDVGFFRISRRPTDPDEGICVRVGNGKIFGATDRGTYWQMSYETTRGGFDRVRHAGLDAFRADLAALVPFLADRVHELRSLDDISLLEARIDRLARWHRPGLLFIGDAAHAMSPVAGFGVNLAVQDAVATANALCAPLLRAQRTGAAFDDSLLTKVRRRRLVATALSQGLQRATQRFGIDTTLNGSGQPPAPRLFERFRPAQLLMSRVIGVGFRPEHIRTPPARPADHEKDPT	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	88.45	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	924	rifampin; rifaximin; rifapentine
BGC0001334.1|Cladoniamide_11 # 14535 # 15569 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.755	BGC0001334.1|Cladoniamide_11 	14535	15569	+	Loose	600	27.7202	CfxA6	26.67	3003097	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGAGCGCAGCCGACCCCGGGGGGACCGGGCCCGCCCCGGCCGACCGGATGATGTCGATGATCACCGGCTACTGGGTGACCCAGATCGTCCGGACCGTCGCCGAGCTGTCGATCCCCGACCAGCTCGCCGAGGGCCCGCTGACGGCCGCCGAACTCGCCGCGCGGATCGACGCCGACCCCGACGCGGTCGCCCGGCTGCTGCGGGCGTGCGCGTCGCTGGGGCTCACCGAGGCGGACGACCGGCGCGCGTTCCACCGCACACCCCTGCTCGACACCCTGCGCGCCGGGACCCCGCACTCCCTGCGGACGATCGCGCTGGTCCACGGCTCACCCGGCCACTGGCTGCCCTGGGGCCTGCTCCCCGACGCCGTACGGTCGGGGACCCCGCAGACCGGGGCCGCCCTCGGCCGGGACATCTGGGCCCACTTCCTCGCCCACCCCGAGGAGGGCGAACGCTTCGCGACCTCCATGACCGAACTGACCGCCGGGCTCGCCGAGGAGGTCGCCGCCCTGATCGACACGGACGGCGTCGGGGTCGCCGTGGATGTGGGGGGCGCGAACGGCGCGCTGGTGCACGCGCTGCTGCGCGGCGACCCACGACCGCGCGGGGTGGTCGTGGACCTGCCCGCCGTCGAGGAATCCGCCCGCGCCGAAGCGCGCGAGGCGGGACTCGCCGACCGGGTCACCGTGGTCGGCGGTTCCTTCTTCGACCCGCTGCCCCGGGGCGACCTCTTCCTGCTCAAGGCGGTCCTGCACAACTGGGACGACGACGCCTGCACGGCCATCCTGCGCAACTGCCGCGCCGCGCTGAACCCGGGGGGCCGGGTGATCGTGGTGGAGATGCCCCTGGGCCCGCTCGGCGAGCCCGGCTTCGCCCCCCTCCTGGACCTCAACATGCTCGCGGTCCTCCCGGGCCGCGAACGCGACCTCCCGCACTACGACGCCCTCTTCGCGGCCGCCGGCCTGCGCCGCACGGGGATCACCCCCACCCGTTCCCCCCAGCGGCTCATCACCGCGGTAACGGCCGGGAGCTGA	MSAADPGGTGPAPADRMMSMITGYWVTQIVRTVAELSIPDQLAEGPLTAAELAARIDADPDAVARLLRACASLGLTEADDRRAFHRTPLLDTLRAGTPHSLRTIALVHGSPGHWLPWGLLPDAVRSGTPQTGAALGRDIWAHFLAHPEEGERFATSMTELTAGLAEEVAALIDTDGVGVAVDVGGANGALVHALLRGDPRPRGVVVDLPAVEESARAEAREAGLADRVTVVGGSFFDPLPRGDLFLLKAVLHNWDDDACTAILRNCRAALNPGGRVIVVEMPLGPLGEPGFAPLLDLNMLAVLPGRERDLPHYDALFAAAGLRRTGITPTRSPQRLITAVTAGS	MSNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIVAPLLDKEGVVIAHKTGSGNVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQASQFVAHISAVVYSLLINTALN	103.93	gnl|BL_ORD_ID|240|hsp_num:0	268			630	810	
BGC0001334.1|Cladoniamide_12 # 15891 # 18836 # -1 # ID=1_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.750	BGC0001334.1|Cladoniamide_12 	15891	18836	-	Loose	390	35.039	evgA	35.09	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACGGGAAGACCCTGGAAAAGCCTGACGACCCAGTCCCCCAGTTCCCGCCGGCCGTGGGCCGTCCGCTCCGTGGCCGCGACGGCCATCTGGAGCAGATACGCGCCTCGTTGCGGGCGACCGCCGAGAGCCGCCAAGGCGGCATCACCCTCCTGGAATCCCCCGCGGGAAGCGGCAGGACACGGCTCCTCCAGGAGACGGGCGCCCTCGCCGAGGGACTCGGCTTCACCGTGATCGACTGCTCCGCCGGGGGCGCCTGGCGCGGCGAGGAGGCGGCTTCGCCCGCCGTCGGCGCGGGCCGGGCCGTCGCCCCGCGGGTGCCGCGCCCGGTACGTCCGGCGGGCCCCGTGCAGGTCCAGGCCCAGATCGACGCGGGGCTGCGGCGCGGCCCGGTGCTCGTGCTCGTGGACGACGCGCAGTGGGCCGACCCGGTGCAGCTGCGGACCCTGTGCGGACTGGCGCTCAAACTGCTGGCCGCTCCCGTGCGGTGGCTGCTCACGATGCGTACGGAGGACGCGCGGTCCGCGAACAGCCTCCTGCTGCGCAACCTGACCATCCACCGGGCGGAATGGCTCCCGCAGCTCGACGCGCTCGACGACCGGGCGGTCACCGAACTGATGGGCGACCTCCTGGGCGCCCGTCCCAGCGACGACGTACGGGCCCTCGGCGAGAGCCTGGGCGGCAGCCCGCAGGCGATCGTGGAGCTGGTGCGCGGTCTGCTGGACGAGCAGTGCCTGCGGATCACCGGGGGCACCGTGTCGCTCGTCGCGGAACCGCTCGCCTCCGGCTTCACCTCCGCCGTCGCCCCCGACCCCGGGGCGCATCTGCCGCGCGCGTTCCTGCGGCTGATGCACGACCGGCTCGACCGGCTCGCGCCCGGCACCCAGCGGCTCCTCCAGGTCGCGGCCGTCCTCGGTCCGTCCTTCATGCCGCGCGACCTGGCGGAGATGGCCGACGAGCGACCCGTGCAACTCCTCGGCCCGCTCCAGGAGTCACTGGCAGCGGGACTCCTCACCAGCGGCACCGAGGAGTTCTCCTTCCACCGCGAACCGATCTGGTACGCGGTGCTGGGCACCGTTCCACCGCTGATGCGGTCCCTGCTGCACCGGCAGGCGGCGAACATGATCCTCGGTCAGCTGGGGGACGGCACCGCCGCGGCGGTGCATCTGGTGCACTGCGCCCAGTCCGACGACGACCAGGCCATCACCACCATCCGGGAGGCGGCGGACCGGCTGCTCCCGGTGTCCCCGCAGGCCGCCGCCGCGCTCGCGCTGCGCGGTCTGGAGATCACCACGCCGACCCAGCCCGAGCACATCGCGCTGGCCACCACGGCGACCGCCGCGCTCGTCCGCTCGGGCAGTCTGCACCGGGCGGTGGACGTCGCCGAACGCGTGGTCGCCGGACACCGGCGCGCGCATCCGGCGCGGCCCGGCGACGGCGCCCGCCAGGACGCCCGGACCTGGCCGCTGCGGGCCTGGCTCGCGACCGCGCTGCTGCTGCGCGGGGAGGCCGCCTCCGTACCGGGGATCCTGTGCGACGCCGCGGCGGGCGGGCCCCCGGACCCGGCCGCGGACGGGGCGGGCCCCGGCCAGGGCAGCCCGTCGCCGCTGCTGCTGCGGCTCACCATGCTGTCCCACACCGACGAACGGGCCGCGCTGGCGGCGGCCGACGAGGTACTGAAGGACGAGTCCGCCCACGAACGCGACGTGTGTACGGCGGCCCGCAACATCCGGGCGATGTCCCTGTGGGGCGACGGACGGATCGACGAGTCGCTGGGCCTGCTGGAGCGCACCCCCGCGCACGGTGACGACGGCACCGGCATCTGGCAGAACAACTCCCTGTGGAACACGGCGTGGATCCTGATCAAGCTCCGCGACCTCGACGGGGCCGCGGTCATGGTCGAAGCGGTCCGGCGCACCATCGACGCCGACTCCAACGGGGTACTGGACCCGTTGCAGTTCGCGTTGCGGTCCTGGGTGAGCTTCGCCCGGGGCGACCTGGCCGAGGCCGAGCAGCTCGCGCGGGCCGGGATCACCGCGTCCGACGCGGCCCGGATGCCGCTGTGCGAACCGCATCTGCGGGCCGTGCTGGTGGCCGTGGCGCTGCGCCGGGGTGATCTGGCCGAGGCCCTGGAACGGCAGGGCCACTGGGAGTCCGCCACCGTGCCCGGCGGGCCGTCGCGCCCGTGGTGGGCCATGCGGTGCCTGATCACAGCGCAGGTGACGGCCGCGCGGAGGGGGGCCGAACAAGCGCTGGAGGTACTGCGGGACGCCCGTCACGACGAAGGGCTGCGGCGACGGCTGGTGCTGGAGGACCCGTCGGCGACGGCGTGGTGCGTCCGTACCGCGCTGGCCGCCGGGGACCGGGAGTTCGCGGCGCGGATCGCGGACTGCGCCGGGGAGGTGGCGGCGCTGGCCCGGACGCGGCCCGCGACGGGTGCGGCGGCGGCGCATGGGCGGGCCCTGCTGACCGGCGATGTGACCCTGCTGGCCAGGGCCGTCGACGGGTACGGGGACCCCTGGGCCGTCGCCTCGGCCACCGAGGATCTGGGCGTGCTGCTGTGCGGGGGCGACCGGGAGGGGGCGATCGGCGCGTTCAACGCGGCCATGGCCGGGTACGACGGGCTGGGCGCCAAACGCGACTCGGCGCGGGTGCGGCGGCGGCTGCGGCGGCTCGGGGTGCGGCGGCGGCACTGGAATCTGGTCGCCCGGCCGCAGACCGGCTGGGACAGTCTCACCGGGGCGGAGGAGAAGGTGGCGCAGCTCGTCGCCCGGGGGCTGACGAACCGGCAGGTGGCCGGTGAGCTGTTCATCTCGCCGCACACGGTGAGTTTCCATCTGCGGCAGATCTACCGGAAGCTGGCGATCCAGTCGCGGGTGGATCTGACCCGGATCGTGTGTGCGCCGGGGGCGAGAACGGCGCCGGCGCCGTTCGGGGCCGAGTAG	MNGKTLEKPDDPVPQFPPAVGRPLRGRDGHLEQIRASLRATAESRQGGITLLESPAGSGRTRLLQETGALAEGLGFTVIDCSAGGAWRGEEAASPAVGAGRAVAPRVPRPVRPAGPVQVQAQIDAGLRRGPVLVLVDDAQWADPVQLRTLCGLALKLLAAPVRWLLTMRTEDARSANSLLLRNLTIHRAEWLPQLDALDDRAVTELMGDLLGARPSDDVRALGESLGGSPQAIVELVRGLLDEQCLRITGGTVSLVAEPLASGFTSAVAPDPGAHLPRAFLRLMHDRLDRLAPGTQRLLQVAAVLGPSFMPRDLAEMADERPVQLLGPLQESLAAGLLTSGTEEFSFHREPIWYAVLGTVPPLMRSLLHRQAANMILGQLGDGTAAAVHLVHCAQSDDDQAITTIREAADRLLPVSPQAAAALALRGLEITTPTQPEHIALATTATAALVRSGSLHRAVDVAERVVAGHRRAHPARPGDGARQDARTWPLRAWLATALLLRGEAASVPGILCDAAAGGPPDPAADGAGPGQGSPSPLLLRLTMLSHTDERAALAAADEVLKDESAHERDVCTAARNIRAMSLWGDGRIDESLGLLERTPAHGDDGTGIWQNNSLWNTAWILIKLRDLDGAAVMVEAVRRTIDADSNGVLDPLQFALRSWVSFARGDLAEAEQLARAGITASDAARMPLCEPHLRAVLVAVALRRGDLAEALERQGHWESATVPGGPSRPWWAMRCLITAQVTAARRGAEQALEVLRDARHDEGLRRRLVLEDPSATAWCVRTALAAGDREFAARIADCAGEVAALARTRPATGAAAAHGRALLTGDVTLLARAVDGYGDPWAVASATEDLGVLLCGGDREGAIGAFNAAMAGYDGLGAKRDSARVRRRLRRLGVRRRHWNLVARPQTGWDSLTGAEEKVAQLVARGLTNRQVAGELFISPHTVSFHLRQIYRKLAIQSRVDLTRIVCAPGARTAPAPFGAE	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	480.88	gnl|BL_ORD_ID|936|hsp_num:0	1015			411	582	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
